Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Biodegradable Stent Successful in Human Trial

Could be the future of these artery-opening devices, German researchers report.

By Ed Edelson
HealthDay Reporter


Related Encyclopedia
 border=
Alzheimer's Disease
Aneurysms
Angina Pectoris
Angiogram
More...

Related Healthscout Videos
 border=
Howard: The Helping Hand for Stroke Survivors
Fixing Torn Hearts
Medicine's Next Big Thing? Growing Hearts
How can a supportive family help?
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Angioplasty
Coronary Bypass Surgery
Erectile Dysfunction
More...

Related Drug Information
 border=
Accupril
Actonel
Altace
Avapro
More...

Related News Articles
 border=
Drowsy Drivers Make Holiday Weekend Among the Most Dangerous
Health Tip: Talk to Loved Ones About Your Alzheimer's
Obese Patients at Greater Infection Risk After Hip Replacement
Carbon Monoxide May Help Bypass Surgery Patients
More...

THURSDAY, May 31 (HealthDay News) -- A stent that biodegrades and vanishes from an artery in a matter of months has successfully passed a major test in humans, German researchers report.

The device, made of magnesium, is one of many different biodegradable stents that together represent the future of these artery-opening devices, said Dr. Raimund Erbel, professor of medicine at the West German Heart Center in Essen, and lead author of a report on the trial in the June 2 issue of The Lancet.

Text Continues Below



Stents are tiny, implanted mesh tubes that prop open failing arteries.

"In the long run, a biodegradable stent is best for those who need a coronary stent," Erbel said. "When such a stent has done its job, you don't need it any more. In the long run, its presence can cause problems."

A number of cardiologists and companies in countries across the world are working to develop stents that are broken down by the body once they have succeeded in keeping blood flowing through an artery. Most of this work is going on outside the United States, with reports on early trials coming from China, Japan, Finland, Germany, and elsewhere.

For example, at a heart meeting earlier this year, a group at Erasmus University in Amsterdam reported on a biodegradable stent they placed in 30 cardiac patients. The devices behaved very much like standard metal stents over the relatively brief period of a month, the researchers reported. The patients are still being followed to determine exactly when and how the stents disappear.

In this new trial, Erbel and his colleagues implanted 71 magnesium stents in 63 patients.

They reported that the safety record of the devices remained good after 12 months, with not a single case of clotting noted within the stent and no incidents of heart attack or death among patients. The diameter of the treated arteries increased slightly as the magnesium was absorbed by the body, being replaced by natural calcium and phosphorus.

Page:  1 | 2 | Next >>

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 6/1/2007

Related Links
 border=
From Healthscout's partner site on heart disease, MyHeartCentral.com
Learn about heart disease symptoms.
Get more information on heart disease treatment for your health!
What can you do to prevent heart disease? Prevention details here.





New Features

New ADHD Site!

SOURCES: Raimund Erbel, M.D., professor, medicine, West German Heart Center, Essen; Joachim Kohn, Ph.D., director, New Jersey Center for Biomaterials, Piscataway; June 2, 2007, The Lancet


We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2008. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map